Company Research Report: Viome Life Sciences
Company Overview
Name, Mission of the Company
- Name: Viome Life Sciences
- Mission: To digitize, decode, and decipher human biology for the prevention, earliest diagnosis, and treatment of chronic diseases and cancer.
Founding Details
- Founded: 2016
- Founder: Naveen Jain, an entrepreneur and philanthropist focused on solving global challenges through innovation.
Key People in the Company
- Naveen Jain: Founder & CEO
- Guruduth Banavar, PhD: Founding CTO & Head of Discovery AI
- Momo Vuyisich, PhD: Founding CSO & Head of Clinical Research
- Stephen Barrie, ND, PhD: VP & Head of Clinical Nutrition
- John Blanchard: COO
- Helene Vollbracht: Head of Brand
- Rodrigo Hutt: VP & GM of Consumer Group
- Damon Tanton, MD: Chief Medical Officer
Headquarters
- Location: Bellevue, Washington
Number of Employees
- Information on the number of employees is not available.
Revenue
- Information on company revenue is not available.
Company Recognition
- Known for: Groundbreaking work in utilizing metatranscriptomics and an advanced AI platform to prevent chronic diseases and optimize human health, with a focus on the microbiome.
Products
Product Offerings
1. Direct-to-Consumer Health Services:
- Description: A service that analyzes gene expressions (RNA) to provide personalized health insights and precision nutrition recommendations.
- Key Features: Utilizes a platform of over 300,000 samples to enhance the understanding of human biology and develop predictive biomarkers and precision therapeutics.
2. Diagnostic Tests:
- Description: Predictive biomarkers for chronic diseases, cancers, and aging.
- Key Features: Includes the FDA Breakthrough Device Designation for early-stage throat and oral cancer detection.
3. Precision Therapeutics:
- Description: Development of precision therapeutics including drugs and vaccines based on diagnostic insights.
- Key Features: Evaluation of drug effectiveness, particularly immunotherapy dependent on gut microbiome.
Recent Developments
New Product Launches and Features
- Viome has expanded its mRNA technology platform and AI for advancing diagnostics and therapeutics targeting Alzheimer's disease, metabolic diseases, and mental health conditions.
- The partnership with GSK for developing new therapeutic interventions for cancers and autoimmune diseases has been enhanced.
Collaborations and Partnerships
- Successful collaboration with GSK leading to FDA breakthrough device designation for early detection of oral and throat cancers.
- Ongoing clinical validation trials for new therapeutics in cancer and autoimmune diseases.
Other Recent Developments
- Raised $54 million in pre-series C convertible funding to research cancer and chronic diseases.
- Relocated laboratory operations to a larger facility in Bothell, Washington, increasing capacity and enabling expansion into 15 new countries.
Research and Development Initiatives
Clinical Trials and Research Areas
- Active involvement in clinical trials targeting metabolic diseases, mental health, and cancer.
- Development of predictive models for glycemic response, obesity, diabetes, depression, IBS, and oral cancer.
- Continued focus on the significant role of the gut microbiome in chronic disease progression.
Publications and Media Presence
Select Publications
- "The salivary metatranscriptome as an accurate diagnostic indicator of oral cancer," NPJ Genomic Medicine, December 8, 2021.
- "Gut microbiome activity predicts risk of type 2 diabetes and metformin control," Pre-print on medRxiv, August 18, 2021.
Media Coverage
- MindBodyGreen: Nurse’s review of Viome’s Microbiome At-Home Test, January 4, 2023.
- Cision: Unveiling CancerDetect® for oral and throat cancer detection, August 4, 2022.
- New Scientist: Accuracy of home screening tests for oral or throat cancer, August 4, 2022.
Contact Information
- Partnerships: businesspartners@viome.com
- Press Inquiries: press@viome.com
- Events and Speaking Inquiries: events@viome.com
This report provides an informative snapshot of Viome Life Sciences, emphasizing its mission, products, recent developments, key leadership, and ongoing research initiatives aimed at revolutionizing healthcare through precision diagnostics and therapeutics.
